About this trial

The ACHDi Registry study will create a foundational database for adult congenital heart disease interventions. This Pan-Canadian Registry will collect clinical and patient-reported information that will enable the evaluation of care processes and outcomes in five most common ACHDi interventions by enabling prospective and retrospective registry-based studies to answer important clinical practice and policy-relevant questions.

Eligibility criteria

Qualifiers

participants must be 18 years or older referred for intervention for one of five ACHD conditions including diagnostic catheterization for complex ACHD patients (Tetralogy of Fallot, Fontan, and transposition of the great vessels, single ventricle, truncus arteriosus); transcatheter closure of atrial septal defects; transcatheter closure of patent foramen ovale; coarctation of aorta stenting, and percutaneous pulmonary valve implantation.

Disqualifiers

participants below the age of 18

participants residing outside of Canada

Trial design

Treatments tested in this trial

  • Participants undergoing ACHD intervention

Treatment groups

9,000 Participants
are divided into 1 treatment group

Locations

1
Toronto General HospitalM5G 2C4, TorontoOntario, Canada

Sponsors and collaborators

University Health Network, Toronto

Lead sponsor